Steward Partners Investment Advisory, LLC Infla Rx N.V. Transaction History

Steward Partners Investment Advisory, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	BUY	$2.25 - $3.03 $8,100 - $10,908	3,600 Added 300.0%	4,800 $12,000
Q2 2021 Aug 13, 2021	SELL	$2.72 - $4.04 $680 - $1,010	-250 Reduced 17.24%	1,200 $4,000
Q1 2021 May 14, 2021	SELL	$3.62 - $6.34 $2,715 - $4,755	-750 Reduced 34.09%	1,450 $5,000
Q4 2020 Feb 11, 2021	BUY	$3.82 - $5.32 $3,438 - $4,788	900 Added 69.23%	2,200 $11,000
Q3 2020 Oct 30, 2020	SELL	$3.7 - $5.47 $740 - $1,094	-200 Reduced 13.33%	1,300 $6,000
Q2 2020 Aug 06, 2020	BUY	$4.59 - $8.96 $6,885 - $13,440	1,500 New	1,500 $7,000

12.9M

19.3K

Ticker IFRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,203,800
Market Cap $99M
Description
InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.